News

(Bloomberg) -- Kalshi Inc. is seeking approval to expand precious-metals trading on its platform with a popular type of derivative that never expires for gold, silver and platinum.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Campaign After Troops Killed

Investing.com -- U.S. Treasury Secretary Scott Bessent said Tuesday that China has reduced its crude oil purchases by approximately 40% in recent months, a decline he said is significantly reducing Iran's oil revenues.

JPMorgan Chase CEO Jamie Dimon said he isn’t bullish on long-dated Treasurys and stocks at current prices. “I would not be a buyer” of long-dated Treasurys, Dimon said on the “Master Investor Podcast” released late yesterday, citing current interest and inflation rates. Dimon also said he hasn’t bought any stocks recently, noting that corporate profits are currently very high.

SpaceX stock is down 45% from its highs and trades below its IPO price. Is this the contrarian buying opportunity patient investors have been waiting for?

Expedia Group will release its second-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

Parker-Hannifin will release its fourth-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.

NEM heads into Q2 earnings with higher gold prices offset by lower production and rising costs. Margins are expected to be lower Q/Q.

The Clarity Act nears a Senate vote this week after President Trump reportedly agreed to a debated ethics provision. Crypto stocks surge.

Gilead Sciences will release its second-quarter earnings soon, and analysts anticipate a triple-digit profit dip.

Warner Bros. Discovery will release its second-quarter earnings soon, and analysts anticipate a triple-digit profit dip.

Novo alleges that Lilly’s Zepbound advertisements compare the drug’s highest approved dose with lower doses of Wegovy.

The company has a high bar for acquisitions.

The agreement will expand sustainable aviation fuel capacity and infrastructure at five international airport hubs.

According to TheFly, Jefferies downgraded Datadog to ‘Hold’ from ‘Buy’ while raising its price target to $280 from $210.

Motorola Solutions is expected to announce its second-quarter results soon, and analysts predict a single-digit rise in the company’s bottom-line figure.

Northrop Grumman reported better-than-expected second-quarter earnings and raised its full-year financial guidance.

(Bloomberg) -- The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Cam

President Trump announced a fresh round of 50% tariffs on a range of Canadian goods

Microsoft has agreed to spend billions of dollars on Mistral's computing infrastructure in Europe under a deal that will also expand distribution of the French AI startup's ‌technology through the U.S. cloud and software giant, the companies said on Tuesday. As part of the agreement, ‌Microsoft Azure customers will be able to develop software using Mistral's data centers in France, giving Microsoft more capacity in Europe and regulated industries an ​alternative to U.S.-controlled infrastructure. Mistral, meanwhile, has added its AI models called Medium 3.5 and OCR 4 to Microsoft's app builder known as Foundry.

The deal, structured as an all-stock transaction, gives Tempus control of Personalis' NeXT Personal cancer detection test

North American margins drove the beat, yet the automaker lowered net income guidance for a second straight quarter.

Investing.com -- The clash between pharma titans Novo Nordisk and Eli Lilly just escalated from the pharmacy counter to the courtroom. Novo Nordisk Inc. filed a lawsuit in the U.S. District Court for the District of New Jersey against Eli Lilly and Company and Lilly USA, LLC, alleging multiple violations of federal and state false advertising and unfair competition laws under the Lanham Act. The lawsuit takes aim at Lilly’s aggressive direct-to-consumer (DTC) advertising campaigns for its blockb

Microchip Technology is scheduled to post its first-quarter results soon, and analysts predict a triple-digit surge in the company’s bottom-line figure.

Futures rose early Tuesday as Sandisk, Micron and AMD lead an AI rebound. GM and 3M are earnings movers.

Two industrial giants report Q2 results on the same day, and analysts are anything but neutral between them. Before you decide which earnings announcement to watch on July 22, you need to see how these two stack up across every dimension Wall Street actually measures.

Vicor (VICR) delivered earnings and revenue surprises of +67.74% and +3.35%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ozempic maker Novo Nordisk has filed a lawsuit against Eli Lilly, arguing it uses deceptive advertising to mislead consumers. The complaint accuses Eli Lilly of using outdated studies to promote its branded GLP-1 drugs, Mounjaro and Zepbound, as helping consumers lose significantly more weight on average than Novo Nordisk’s Ozempic and Wegovy.

Investing.com -- Northrop Grumman Corporation (NYSE: NOC) reported second-quarter earnings on Tuesday ahead of the open, topping analyst expectations, with the company also raising its full-year guidance.

Memory chip shortages continue to be a problem for most companies.

Halliburton logged higher earnings and revenue in the second quarter thanks to gains in both its North American and overseas markets.